FeMike - I get your argument. However, I find it difficult to come up with any topic LL could talk about that is Phase 3 trial specific and "exciting." She has given numerous talks in the past year about external controls, etc., none of which were PR'd. I have been pretty pessimistic about the company's long delay in announcing TLD, and am wary of a rug pull (again). That said, this situation really seems different, and my best prediction would be a formal company TLD announcement on Tuesday morning with reference to LL's talk shortly thereafter, with the talk addressing the findings and the complexities of the trial. I think we could see a publication soon after as well. It would make little sense given the long delay in announcing TLD to do a PR of this talk presumably discussing TLD unless they knew that additional detail would soon be available in print to address the complexities not covered by a simple TLD announcement that will get the AF's of the world writing critical hit-pieces.